Loading...
Loading...
Analysts at Benchmark downgraded Haemonetics
HAE from “buy” to “hold.” The target price for Haemonetics has been lowered from $49 to $46. Haemonetics shares closed at $42.54 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
